For the quarter ending 2025-12-31, ARWR made $264,033K in revenue. $30,811K in net income. Net profit margin of 11.67%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | 264,033 | -26,266* | 27,767 | 542,709 |
| Research and development | 177,203 | 163,953* | 162,368 | 133,102 |
| General and administrative | 46,021 | 34,912* | 30,949 | 28,405 |
| Total operating expenses | 223,224 | 198,865* | 193,317 | 161,507 |
| Operating income (gain) | 40,809 | -225,131* | -165,550 | 381,202 |
| Interest income | 9,690 | 6,338* | 11,019 | 9,615 |
| Interest expense | 22,505 | 20,329* | 24,382 | 21,639 |
| Other, net | 277 | 4,866* | -176 | 438 |
| Total other expense | -12,538 | -9,125* | -13,539 | -11,586 |
| Income (gain) before income tax expense and noncontrolling interest | 28,271 | -234,257* | -179,089 | 369,616 |
| Income tax expense | 29 | 19,445* | -437 | 1,753 |
| Net income (gain) including noncontrolling interest | 28,242 | -253,702* | -178,652 | 367,863 |
| Net loss attributable to noncontrolling interest, net of tax | -2,569 | 40,735* | -3,411 | -2,582 |
| Net income (loss) attributable to arrowhead pharmaceuticals, inc | 30,811 | -294,437 | -175,241 | 370,445 |
| Basic EPS | 0.22 | -2.285 | -1.26 | 2.78 |
| Diluted EPS | 0.22 | -2.305 | -1.26 | 2.75 |
| Basic Average Shares | 137,039,000 | 128,872,000 | 139,039,000 | 133,363,000 |
| Diluted Average Shares | 140,706,000 | 127,751,000 | 139,039,000 | 134,484,000 |
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)